UDG.L लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (1 Jan 1970 @ 05:30):

Stats
आज की मात्रा	3.14M
औसत मात्रा	2.82M
बाजार मूल्य	0.00
EPS	£0.0573 ( 2019-06-29 )
Last Dividend	£0.125 ( 2021-01-07 )
Next Dividend	£0 ( N/A )
P/E	0.420
ATR14	£0 (0.00%)

UDG Healthcare plc सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध

10 सबसे अधिक नकारात्मक सहसंबंध

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

UDG Healthcare plc वित्तीय

Annual	2020
राजस्व:	£1.28B
सकल लाभ:	£394.83M (30.87 %)
EPS:	£0.373

FY	2020
राजस्व:	£1.28B
सकल लाभ:	£394.83M (30.87 %)
EPS:	£0.373

FY	2019
राजस्व:	£1.30B
सकल लाभ:	£371.14M (28.58 %)
EPS:	£0.231

FY	2018
राजस्व:	£1.32B
सकल लाभ:	£381.60M (29.02 %)
EPS:	£0.0153

Financial Reports:

No articles found.

UDG Healthcare plc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)

UDG Healthcare plc Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.26 - Potential for dividend initiation, but uncertain (5.20%)

Information

First Dividend	£0.00468	1990-01-29
Last Dividend	£0.125	2021-01-07
Next Dividend	£0	N/A
Payout Date	2021-02-05
Next Payout Date	N/A
# dividends	63	--
Total Paid Out	£1.931	--
Avg. Dividend % Per Year	0.00%	--
Score	4.03	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	5.26
Div. Directional Score	8.01	--

Next Divdend (Est)
(2024-06-21)

£0 Estimate 0.00 %

Dividend Stability

0.09 Very Bad

Dividend Score

4.03

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield
1990	£0	0.00%
1991	£0	0.00%
1992	£0	0.00%
1993	£0	0.00%
1994	£0	0.00%
1995	£0	0.00%
1996	£0	0.00%
1997	£0	0.00%
1998	£0	0.00%
1999	£0	0.00%
2000	£0	0.00%
2001	£0	0.00%
2002	£0	0.00%
2003	£0	0.00%
2004	£0	0.00%
2005	£0	0.00%
2006	£0	0.00%
2007	£0	0.00%
2008	£0	0.00%
2009	£0	0.00%
2010	£0	0.00%
2011	£0	0.00%
2012	£0	0.00%
2013	£0	0.00%
2014	£0	0.00%
2015	£0	0.00%
2016	£0	0.00%
2017	£0	0.00%
2018	£0	0.00%
2019	£0	0.00%
2020	£0.168	0.02%
2021	£0.125	0.02%
2022	£0	0.00%
2023	£0	0.00%
2024	£0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for LSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
QXT.L	Ex Dividend Junior	2023-07-27	Sporadic	11	0.46%
GHH.L	Dividend Knight	2023-06-22	Annually	27	0.91%
AMC.L	Dividend Knight	2023-06-01	Insufficient data to determine frequency	2	55.57%
TPFG.L	Dividend Knight	2023-09-21	Annually	11	3.16%
MACF.L	Dividend King	2023-09-14	Semi-Annually	32	1.94%
CREI.L	Dividend Knight	2023-07-20	Quarterly	11	3.34%
RUR.L	Dividend Knight	2023-06-22	Sporadic	20	10.67%
HLCL.L	Dividend Knight	2023-06-22	Semi-Annually	32	1.69%
BARC.L	Dividend Knight	2023-08-10	Annually	32	2.43%
VOD.L	Dividend King	2023-06-08	Semi-Annually	32	4.36%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0726	1.500	8.55	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0526	1.200	8.25	9.90	[0 - 0.3]
returnOnEquityTTM	0.0986	1.500	-0.0160	-0.0240	[0.1 - 1]
payoutRatioTTM	0.453	-1.000	5.47	-5.47	[0 - 1]
currentRatioTTM	1.919	0.800	5.41	4.32	[1 - 3]
quickRatioTTM	0.791	0.800	-0.0553	-0.0442	[0.8 - 2.5]
cashRatioTTM	0.791	1.500	6.72	10.00	[0.2 - 2]
debtRatioTTM	0.167	-1.500	7.22	-10.00	[0 - 0.6]
interestCoverageTTM	8.87	1.000	7.83	7.83	[3 - 30]
operatingCashFlowPerShareTTM	0.926	2.00	9.69	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.774	2.00	9.61	10.00	[0 - 20]
debtEquityRatioTTM	0.299	-1.500	8.81	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.309	1.000	8.19	8.19	[0.2 - 0.8]
operatingProfitMarginTTM	0.0995	1.000	-0.0102	-0.0102	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.785	1.000	6.75	6.75	[0.2 - 2]
assetTurnoverTTM	0.725	0.800	8.50	6.80	[0.5 - 2]
Total Score				10.75

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	36.30	1.000	6.43	0	[1 - 100]
returnOnEquityTTM	0.0986	2.50	-0.0103	-0.0240	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.774	2.00	9.74	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.926	2.00	9.69	10.00	[0 - 30]
payoutRatioTTM	0.453	1.500	5.47	-5.47	[0 - 1]
pegRatioTTM	47.57	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.180	1.000	7.99	0	[0.1 - 0.5]
Total Score				5.26

UDG Healthcare plc

UDG Healthcare plc, together with its subsidiaries, provides advisory, communication, commercial, clinical, and packaging services in the Republic of Ireland, the United Kingdom, North America, and internationally. The company operates in two segments, Ashfield and Sharp. The Ashfield segment offers commercialization services for the pharmaceutical and healthcare industry in the areas of advisory, communications, and commercial and clinical services. This segment supports healthcare professionals and patients at various stages of the product life cycle; and provides field and contact center sales teams, healthcare communications, patient support, audit, advisory, medical information, and event management services to approximately 300 healthcare companies. The Sharp segment provides contract and clinical trial packaging services for the pharmaceutical and biotechnology industries; serialization solutions; and clinical IRT services. The company was formerly known as United Drug plc and changed its name to UDG Healthcare plc in August 2013. UDG Healthcare plc was founded in 1948 and is based in Dublin, the Republic of Ireland.